Top Markets
Coin of the day
Jiangsu Hengrui Medicine Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

600276
Classement en actions #505
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Prix de l'action
$7.99
Capitalisation boursière
$50.98B
Changement (1 jour)
1.45%
Changement (1 an)
-8.42%
Pays
CN
Échange Jiangsu Hengrui Medicine Co., Ltd. (600276)

Catégorie

Historique des divisions d’actions pour Jiangsu Hengrui Medicine Co., Ltd. (600276)
L’action Jiangsu Hengrui Medicine Co., Ltd. (symbole : 600276) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 13, 2026.
Une action 600276 achetée avant le Aug 13, 2026 équivaudrait aujourd’hui à 0 actions 600276.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes